CCR7 and neoplasm: Indeed, mice with GBT treated with blockers of lymphatic proteins, such as chemokine (C-C motif) ligand 21 (CCL21) and C chemokine receptor type 7 (CCR7), did not show the improvement of anti-tumor therapy.203